(Q37026225)

17 August 2017

1 reference

title

Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies (English)

1 reference

17 August 2017

0 references

Kathryn E Webert

1

1 reference

17 August 2017

Christine M Cserti

2

1 reference

17 August 2017

Judy Hannon

3

1 reference

17 August 2017

Yulia Lin

4

1 reference

17 August 2017

Katerina Pavenski

5

1 reference

17 August 2017

Jacob M Pendergrast

6

1 reference

17 August 2017

Morris A Blajchman

7

1 reference

17 August 2017

1 January 2008

1 reference

Transfusion Medicine Reviews

17 August 2017

1 reference

17 August 2017

22

1 reference

17 August 2017

1

1 reference

17 August 2017

1-34

1 reference

Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply

17 August 2017

1 reference

12 December 2020

Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.

1 reference

12 December 2020

Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation

1 reference

12 December 2020

Preclinical safety profile of plasma prepared using the INTERCEPT Blood System

1 reference

12 December 2020

Helinx technology for inactivation of infectious pathogens and leukocytes in labile blood components: from theory to clinical application

1 reference

12 December 2020

Nearly two decades using the check-type to prevent ABO incompatible transfusions: one institution's experience

1 reference

12 December 2020

Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver disease

1 reference

12 December 2020

A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white-light treatment.

1 reference

12 December 2020

The use of riboflavin for the inactivation of pathogens in blood products

1 reference

12 December 2020

Costs and benefits of bacterial culturing and pathogen reduction in the Netherlands.

1 reference

12 December 2020

Economics of pathogen inactivation technology for platelet concentrates in Japan

1 reference

12 December 2020

Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA

1 reference

12 December 2020

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial

1 reference

12 December 2020

Solvent-detergent-treated plasma may be cost-effective.

1 reference

12 December 2020

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light

1 reference

12 December 2020

Viability of red cells prepared with S-303 pathogen inactivation treatment.

1 reference

12 December 2020

Pathogen inactivation: the definitive safeguard for the blood supply

1 reference

12 December 2020

Short communication. Photochemical reactions of riboflavin: covalent binding to DNA and to poly (dA) . poly (dT)

1 reference

12 December 2020

Virus inactivation in blood components by photoactive phenothiazine dyes

1 reference

12 December 2020

Photochemical inactivation of viruses with psoralens: an overview

1 reference

12 December 2020

Pathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference.

1 reference

12 December 2020

Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs

1 reference

12 December 2020

High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes.

1 reference

12 December 2020

In vivo recovery and survival of red cells after photodynamic treatment with thiopyrylium and red light using a canine model.

1 reference

12 December 2020

A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation.

1 reference

12 December 2020

Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials

1 reference

12 December 2020

Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?

1 reference

12 December 2020

Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study

1 reference

12 December 2020

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.

1 reference

12 December 2020

Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.

1 reference

12 December 2020

Pharmaco-economics of blood transfusion safety: review of the available evidence

1 reference

12 December 2020

Cost-effectiveness of solvent/detergent-treated fresh-frozen plasma.

1 reference

12 December 2020

Current status of solvent/detergent-treated frozen plasma

1 reference

12 December 2020

Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

8-Hydroxydeoxyguanosine formation at the 5' site of 5'-GG-3' sequences in double-stranded DNA by UV radiation with riboflavin.

1 reference

12 December 2020

Clinical tolerance of methylene blue virus-inactivated plasma. A randomized crossover trial in 12 healthy human volunteers

1 reference

12 December 2020

A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate.

1 reference

12 December 2020

Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets

1 reference

12 December 2020

White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.

1 reference

12 December 2020

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

1 reference

12 December 2020

If nothing goes wrong, is everything all right? Interpreting zero numerators

1 reference

12 December 2020

Dengue and dengue hemorrhagic fever

1 reference

12 December 2020

Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

Assessment of the economic value of the INTERCEPT blood system in Belgium

1 reference

12 December 2020

Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia

1 reference

12 December 2020

Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects

1 reference

12 December 2020

Photoinactivation of Leishmania donovani infantum in red cell suspensions by a flexible thiopyrylium sensitizer.

1 reference

12 December 2020

Thiazole orange, a DNA-binding photosensitizer with flexible structure, can inactivate pathogens in red blood cell suspensions while maintaining red cell storage properties

1 reference

12 December 2020

Pathogen inactivation of RBCs: PEN110 reproductive toxicology studies

1 reference

12 December 2020

Quality and safety of fresh-frozen plasma inactivated and leucoreduced with the Theraflex methylene blue system including the Blueflex filter: 5 years' experience.

1 reference

12 December 2020

Current performance of patient sample collection in the UK.

1 reference

12 December 2020

The bleeding time as a screening test for evaluation of platelet function

1 reference

12 December 2020

Clinical studies with solvent detergent-treated products

1 reference

12 December 2020

Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses?

1 reference

12 December 2020

In vitro reactions with red blood cells that are not due to blood group antibodies: a review.

1 reference

12 December 2020

Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.

1 reference

12 December 2020

Update of cost-effectiveness analysis for solvent-detergent-treated plasma

1 reference

12 December 2020

An international study of the performance of sample collection from patients

1 reference

12 December 2020

West Nile virus among blood donors in the United States, 2003 and 2004.

1 reference

12 December 2020

Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands

1 reference

12 December 2020

Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function

1 reference

12 December 2020

Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.

1 reference

12 December 2020

Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLAS.

1 reference

12 December 2020

Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light

1 reference

12 December 2020

Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)-photoinactivation

1 reference

12 December 2020

Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States

1 reference

12 December 2020

Cost-effectiveness of transfusing virus-inactivated plasma instead of standard plasma

1 reference

12 December 2020

Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: preclinical studies

1 reference

12 December 2020

Economic analyses of blood safety and transfusion medicine interventions: a systematic review

1 reference

12 December 2020

Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen

1 reference

12 December 2020

Preclinical safety of a nucleic acid-targeted Helinx compound: a clinical perspective

1 reference

12 December 2020

Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients

1 reference

12 December 2020

Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand epidemiology and pathogenesis

1 reference

12 December 2020

Positively charged porphyrins: a new series of photosensitizers for sterilization of RBCs

1 reference

12 December 2020

Managing threats rather than risks in blood transfusion: robust design for a complex system

1 reference

12 December 2020

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance

1 reference

12 December 2020

Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura

1 reference

12 December 2020

The role of toxicology assessment in transfusion medicine

1 reference

12 December 2020

Solvent/detergent-treated plasma: composition, efficacy, and safety

1 reference

12 December 2020

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction

1 reference

12 December 2020

1 reference

12 December 2020

Molecular mechanisms of platelet-mediated leukocyte recruitment during myocardial reperfusion.

1 reference

12 December 2020

Update on pathogen reduction technology for therapeutic plasma: an overview

1 reference

12 December 2020

Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma

1 reference

12 December 2020

Exposure of hematopoietic stem cells to ethylene oxide during processing represents a potential carcinogenic risk for transplant recipients.

1 reference

12 December 2020

Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation

1 reference

12 December 2020

Solvent-detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies

1 reference

12 December 2020

Serious hazards of transfusion: a decade of hemovigilance in the UK.

1 reference

12 December 2020

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

1 reference

12 December 2020

10.1016/J.TMRV.2007.09.001

Identifiers

DOI

1 reference

17 August 2017

0 references

1 reference